The weekly litigation news digest is live. Subscribe now

IP Verse

Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A Medicament

Patent No. EP3977993 (titled "Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A Medicament") was filed by Pfizer on Aug 31, 2015. The application was issued on Jan 31, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KELTIEOct 31, 2024KELTIE
QUIMICA SINTETICAOct 29, 2024AERA
QUIMICA SINTETICAOct 29, 2024BARDEHLE PAGENBERG SL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3977993

PFIZER
Application Number
EP21203965A
Filing Date
Aug 31, 2015
Status
Granted And Under Opposition
Dec 29, 2023
Publication Date
Jan 31, 2024
External Links
Slate, EP3977993B1, Google Patents